Geocann is commited to CBG both in technical formulation as well as global distribution. They are proud to announce the first cannabigerol (CBG) soft gel products that use the multi-patented VESIsorb delivery system for optimal absorption and measured bioavailability.
The first step involves the proprietary extraction technology to isolate and concentrate the CBG. Geocann’s expertise in technical formulation can manage the dissolution, absorption and bioavailability.
The first of the two formulations is a blend of CBG and CBD. The second is a mono-CBG formulation. Also included is BCP which has synergistic effects as agonist for the CB2, 5-HTIA and glycine receptors.
What all of this means for Geocann is that they are leaders in product development in addition to having solutions supported by science. They have been able to address many of the industry’s formulation challenges. The market is demanding more than just CBD and Geocann is prepared to provide just that with more than 30 years of research and product development experience.
There is a lot of interest currently in including CBG in new formulations. There is also a high demand for better solubility and dissolution. These advancements provide consumers with greater benefits which ultimately puts Geocann on top in soft gel capsules, topicals, foods, beverages, and sublinguals.